Forsta Partners with Lumoa to Deliver Powerful, AI-Driven Analytics To CX, EX and Market Research Professionals
Partnership will streamline open-ended feedback using artificial intelligence to drive better-informed decisions NEW YORK and…
Month: November 2021
Covis Significantly Strengthens Global Respiratory Portfolio Through Acquisition of Two Medicines from AstraZeneca
ZUG, Switzerland, Nov. 01, 2021 (GLOBE NEWSWIRE) — Covis Pharma Group (“Covis”), a global specialty…
Verona Pharma Announces November 2021 Investor Conference Participation
LONDON and RALEIGH, N.C., Nov. 01, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA)…
Immunicum to Participate in Multiple Upcoming Industry and Investor Events in November
Press Release 01 November 2021 Immunicum to Participate in Multiple Upcoming Industry and Investor…
DBV Technologies to Highlight New Long-term Data from REALISE Trial at ACAAI 2021
Montrouge, France, November 1, 2021 DBV Technologies to Highlight New Long-term Data from REALISE Trial…
Valneva Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Global Offering to Approximately $102.0 Million
Saint-Herblain (France), November 1, 2021 – Valneva SE, a specialty vaccine company, announced today that…
Hyloris Announces FDA Acceptance of New Drug Application for Maxigesic® IV in Post-Operative Pain
Hyloris to receive $1 million milestone payment Maxigesic® IV has the potential to combat the…
Idorsia to advance cenerimod into Phase 3 development for treatment of patients with systemic lupus erythematosus
Ad hoc announcement pursuant to Art. 53 LR Cenerimod 4 mg showed clinically meaningful improvement…
Addex Therapeutics to Release Q3 2021 Financial Results and Host Conference Call on November 4, 2021
Geneva, Switzerland, November 1, 2021 – Addex Therapeutics (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical…
HUTCHMED and AstraZeneca Initiate SAMETA Global Phase III Trial of Savolitinib in Combination with PD-L1 Inhibitor IMFINZI® in Patients with MET-Driven Advanced Papillary Renal Cell Carcinoma
— Follows multiple global studies of savolitinib in papillary renal cell carcinoma patients including SAVOIR and…
LianBio Announces Pricing of Initial Public Offering
SHANGHAI, China and PRINCETON, N.J., Oct. 31, 2021 (GLOBE NEWSWIRE) — LianBio, a biotechnology company…
Orphazyme provides regulatory update following Type A meeting with FDA on arimoclomol in Niemann-Pick disease type C
Orphazyme A/SCompany announcement No. 24/2021Inside informationCompany Registration No. 32266355 Progress made in understanding potential resolution of…
Bango and Microsoft expand access to Microsoft 365 subscriptions
First launch in UK CAMBRIDGE, United Kingdom, Nov. 01, 2021 (GLOBE NEWSWIRE) — Bango (AIM:…
Datametrex Launches Beta Medi-Call In-Person Patient Care
Toronto, Ontario–(Newsfile Corp. – November 1, 2021) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB:…
Xigem Technologies Announces Binding Letter of Intent to Acquire Assets of Cylix Data in $32.35 Million Transaction
Deal Marks Xigem’s Expansion into Data Sector and Values Xigem at a 300% Premium to…
VOOPOO with Drag Nano 2 Leads Cool Guys ‘Back to 80s’
SHENZHEN, CHINA, Nov 1, 2021 – (ACN Newswire) – The labels of ‘fashion’, ‘vitality’, and…
Cross-Chain Scaling Solution BTTC Officially Goes Live, TRON Aims at “Connecting All Chains”
SINGAPORE, Nov 1, 2021 – (ACN Newswire) – TRON, a leading public chain, is pleased…
TOYOTA GAZOO Racing to Reproduce and Sell Spare Parts for the AE86 Corolla Levin / Sprinter Trueno
Toyota City, Japan, Nov 1, 2021 – (JCN Newswire) – TOYOTA GAZOO Racing (TGR) has…
HISTORIC Hypercar Title for TOYOTA GAZOO Racing
Toyota City, Japan, Nov 1, 2021 – (JCN Newswire) – TOYOTA GAZOO Racing made endurance…
The CREB-binding protein (CBP)/beta-catenin inhibitor E7386, co-created by Eisai and PRISM BioLab, achieved the clinical POC (Proof of Concept)
TOKYO, Nov 1, 2021 – (JCN Newswire) – Eisai Co., Ltd. and PRISM BioLab Co.,…